Categories AlphaGraphs, Earnings, Technology
ON Semiconductor’s Q2 results decline; stock falls on disappointing revenue guidance
ON Semiconductor’s (NASDAQ: ON) bottom and top-line results for the second quarter of 2019 declined from the prior year. While earnings came in line with analysts’ predictions, revenue missed estimates. The company also reported weak guidance for Q3. Shares of ON Semiconductors were down about 7% in the pre-market trading hours.
On a non-GAAP basis, the semiconductor firm earned $0.42 per share on revenue of $1.35 billion, representing a 9% decline in EPS and a 7% decline in revenue. On a GAAP basis, EPS declined 31% year-over-year to $0.24. The market had expected ON to earn $0.42 per share on revenue of $1.38 billion.
“Business conditions continue to be soft, and we expect to see sub-seasonal demand trends in the near-term, as geopolitical factors will likely continue to weigh on demand,” said CEO Keith Jackson.
Based on product booking trends, backlog levels, and estimated turns levels, the company anticipates 2019 third quarter revenue to be approximately $1.36 billion to $1.41 billion. Gross margin is expected to be 35.2% to 36.2% on a GAAP basis and 36.7% to 37.7% on a non-GAAP basis.
During the second quarter, ON Semiconductor signed a definitive agreement to acquire, in a phased transaction, a 300mm fab located at East Fishkill, NY and related assets from GLOBALFOUNDRIES. The company also closed its previously announced acquisition of Quantenna Communications, a provideer of connectivity semiconductor solutions for Wi-Fi, in the second quarter.
ON stock had gained 21% since the beginning of 2019, while it had dropped 7% in the trailing 12 months.
Most Popular
CVX Earnings: Chevron reports lower revenue and profit for Q1 2024
Energy exploration company Chevron Corporation (NYSE: CVX) announced first-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation was $5.50 billion or
ABBV Earnings: AbbVie reports lower adj. profit for Q1 2024; revenue edges up
Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced first-quarter 2024 financial results, reporting a decline in adjusted earnings and a modest rise in revenues. The company reported worldwide net
CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q1 2024 financial results
Colgate-Palmolive Company (NYSE: CL) reported first quarter 2024 earnings results today. Net sales increased 6.2% year-over-year to $5.06 billion. Organic sales increased 9.8%. Net income attributable to Colgate-Palmolive Company was